Toggle Main Menu Toggle Search

Open Access padlockePrints

Phorbal ester and bryostatin effects on growth and the expression of estrogen and TGF-beta in breast-tumor cells

Lookup NU author(s): Dr Joyce Nutt, Professor John LunecORCiD


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


The phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA) (10 nM) produced a marked reduction in the growth, measured by thymidine uptake, of MCF-7 cells in full growth medium, but had only a small effect on MDA-MB-231 and T47D cells. Bryostatin alone also inhibited growth but to a lesser extent than seen with TPA. The effect of TPA on MCF-7 cells was partially reversed by bryostatin, added simultaneously or after TPA, suggesting bryostatin does not simply mimic TPA in this system. Even though both are believed to act via effects on protein kinase C, bryostatin appears to act as an antagonist to the effect of TPA as well as a partial agonist on its own. When the oestrogen receptor positive MCF-7 and T47D cells were maintained in charcoal stripped serum, the increase in DNA synthesis on stimulation with oestradiol was inhibited with 50 nM TPA in MCF-7 cells but not in T47D cells. The effects of these treatments on the expression of two well characterised oestrogen responsive genes pNR2(pS2) and pNR100 (Cathepsin-D) were examined. Rather than preventing transcription of these oestrogen responsive genes, TPA alone increased pNR2 and pNR100 levels in MCF-7 cells and the combined effect of oestradiol and TPA had a marked synergistic effect in increasing the transcript levels of these genes. In T47D cells pNR2 transcripts were not detected and the increase in pNR100 mRNA levels were not affected by TPA. We conclude that the inhibitory effects of TPA on the growth stimulation of MCF-7 cells by oestradiol was not due to a general inhibition of the expression of oestrogen responsive genes. An alternative possibility examined was that the growth inhibitory effect of TPA on MCF-7 cells might be due to stimulation of TGF-beta-1, acting as an autocrine inhibitory growth factor. Oestradiol treatment of MCF-7 cells reduced the levels of TGF-beta-1 mRNA whereas TPA produced a marked increase. The combined effect of TPA and oestradiol further increased TGF-beta-1 mRNA above the levels seen with TPA alone. Bryostatin had little effect on TGF-beta-1 expression either alone or in combination with oestradiol. These observations are consistent with the hypothesis that the inhibitory effect of TPA on MCF-7 cells may be partly due to autocrine inhibition by TGF-beta-1.

Publication metadata

Author(s): Nutt, J.E., Harris, A.L., Lunec, J.

Publication type: Article

Publication status: Unknown

Journal: British Journal of Cancer

Year: 1991

Volume: 64

Issue: 4

Pages: 671-676

Print publication date: 01/10/1991

ISSN (print): 0007-0920

ISSN (electronic): 1532-1827